# A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.

> **NCT03101501** · PHASE4 · TERMINATED · sponsor: **Key-Whitman Eye Center** · enrollment: 9 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** Mitomycin c
- **DEVICE:** Raindrop Near Vision Inlay

## Key facts

- **NCT ID:** NCT03101501
- **Lead sponsor:** Key-Whitman Eye Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-14
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The manufacturing company of the Raindrop Corneal Inlay has stopped distribution or sales of the product.
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101501, "A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03101501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*